NexImmune, Inc. (NASDAQ:NEXI – Get Free Report)’s share price fell 1.4% on Wednesday . The stock traded as low as $2.70 and last traded at $2.76. 5,864 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 1,139,655 shares. The stock had previously closed at $2.80.
NexImmune Trading Up 2.2 %
The business’s 50-day simple moving average is $3.16 and its 200-day simple moving average is $5.20. The company has a market cap of $3.78 million, a PE ratio of -0.11 and a beta of 1.95.
NexImmune (NASDAQ:NEXI – Get Free Report) last posted its quarterly earnings results on Monday, May 20th. The company reported ($2.21) earnings per share for the quarter.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Read More
- Five stocks we like better than NexImmune
- What Are the FAANG Stocks and Are They Good Investments?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What is a SEC Filing?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
